|
Volumn 16, Issue 16, 2002, Pages 1507-1514
|
Rapid quantitation of globotriaosylceramide in human plasma and urine: A potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BODY FLUIDS;
DISEASE CONTROL;
ELECTRODEPOSITION;
ELECTRODES;
ENZYMES;
MASS SPECTROMETRY;
ANDERSONS;
ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY;
ENZYME REPLACEMENT THERAPY;
ESI-MS-MS;
FABRY DISEASE;
FLOW INJECTION ANALYSIS;
GLOBOTRIAOSYLCERAMIDE;
HIGH-THROUGHPUT ANALYSIS;
HUMAN PLASMAS;
HUMAN URINE;
ELECTROSPRAY IONIZATION;
ALPHA GALACTOSIDASE;
CERAMIDE TRIHEXOSIDE;
GLOBOTRIAOSYLCERAMIDE;
RECOMBINANT PROTEIN;
ADULT;
ARTICLE;
BLOOD;
CHEMICAL COMPOSITION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
ENZYME BLOOD LEVEL;
ENZYME IMMUNOASSAY;
ENZYME REPLACEMENT;
FABRY DISEASE;
FEMALE;
FLOW INJECTION ANALYSIS;
HUMAN;
INTERMETHOD COMPARISON;
MALE;
MASS SPECTROMETRY;
METHODOLOGY;
PATIENT MONITORING;
QUANTITATIVE ANALYSIS;
SENSITIVITY AND SPECIFICITY;
SIGNAL NOISE RATIO;
STANDARD;
TANDEM MASS SPECTROMETRY;
TEMPERATURE;
URINALYSIS;
URINE;
ELECTROSPRAY MASS SPECTROMETRY;
ALPHA-GALACTOSIDASE;
FABRY DISEASE;
FEMALE;
HUMANS;
MALE;
RECOMBINANT PROTEINS;
REFERENCE STANDARDS;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
TEMPERATURE;
TRIHEXOSYLCERAMIDES;
|
EID: 0035984619
PISSN: 09514198
EISSN: None
Source Type: Journal
DOI: 10.1002/rcm.728 Document Type: Article |
Times cited : (53)
|
References (10)
|